Skip to main content
Journal of Pharmaceutical Analysis logoLink to Journal of Pharmaceutical Analysis
. 2024 Mar 19;11(3):R1. doi: 10.1016/j.jpha.2024.100963

Retraction notice to “A DNA-based nanocarrier for efficient cancer therapy” [J. Pharm. Anal. 11 (2021) 330–339]

Muhammad Abbas a, Mirza Muhammad Faran Ashraf Baig b, Yaliang Zhang a, Yu-Shun Yang a, Songyu Wu a, Yiqiao Hu a,c,, Zhong-Chang Wang a,⁎⁎, Hai-Liang Zhu a,⁎⁎⁎
PMCID: PMC11364892  PMID: 39221177

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy).

This article has been retracted at the proactive request of the Corresponding Authors.

The article duplicates significant parts of a paper that had already appeared in Pharmaceutical Research, volume 37 (2020) article number 75. [https://doi.org/10.1007/s11095-020-02803-1]. One of the conditions of submission of a paper for publication is that authors declare explicitly that the paper has not been previously published and is not under consideration for publication elsewhere. Re-use of any data should be appropriately cited. As such this article represents a misuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.

Contributor Information

Yiqiao Hu, Email: huyiqiao@nju.edu.cn.

Zhong-Chang Wang, Email: wangzhongchang2006@163.com.

Hai-Liang Zhu, Email: zhuhl@nju.edu.cn.


Articles from Journal of Pharmaceutical Analysis are provided here courtesy of Xi'an Jiaotong University

RESOURCES